EGFR inhibitor and chemotherapy combinations for acquired TKI resistance in EGFR-mutant NSCLC models
Crossref DOI link: https://doi.org/10.1007/s12032-015-0627-6
Published Online: 2015-06-17
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Laurila, Niina
Koivunen, Jussi P.
Funding for this research was provided by:
Sigrid-Juselius Foundation
Thelma Mäkikyrö Foundation
Text and Data Mining valid from 2015-06-17